rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2003-10-14
|
pubmed:abstractText |
The promoter of local immunity Heponum contributes to the restoration of eubiosis and normalization of showings of the immune status in patients with post-infection IBS. It is recommended to include Heponum in the complex therapy of chronic bowels diseases with the purpose of the restoration of normal microbiocenosis.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1682-8658
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
66-9, 118
|
pubmed:dateRevised |
2007-12-13
|
pubmed:meshHeading |
pubmed-meshheading:14556551-Adjuvants, Immunologic,
pubmed-meshheading:14556551-Adult,
pubmed-meshheading:14556551-Bacterial Infections,
pubmed-meshheading:14556551-Female,
pubmed-meshheading:14556551-Humans,
pubmed-meshheading:14556551-Immunity, Cellular,
pubmed-meshheading:14556551-Intestinal Diseases,
pubmed-meshheading:14556551-Intestines,
pubmed-meshheading:14556551-Irritable Bowel Syndrome,
pubmed-meshheading:14556551-Middle Aged,
pubmed-meshheading:14556551-Oligopeptides,
pubmed-meshheading:14556551-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Hepon, promoter of local immunity in the complex therapy of dysfunctional microflora in bowel disorders].
|
pubmed:affiliation |
Central Scientific Research Institute of Gastroenterology, Moscow.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|